P33 Thirty-six-month amyloid PET results show continued reduction in amyloid burden with gantenerumab

Autor: Klein, G., Duning, T., Delmar, P., Kerchner, G.A., Hofmann, C., Abi-Saab, D., Ristic, S., Davis, A., Voyle, N., Baudler, M., Fontoura, P., Doody, R.
Zdroj: In Clinical Neurophysiology April 2020 131(4):e195-e195
Databáze: ScienceDirect